Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionPerformance Shares · Derivative | 5,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 17 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,015 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
GrantMarket Share Units · Derivative | 5,021 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 16 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,021 Underlying: Common Stock, $0.10 par value · 5,021 shares Expires 2028-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F11 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionMarket Share Units · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 15 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,102 Underlying: Common Stock, $0.10 par value · 1,050 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionMarket Share Units · Derivative | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 14 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838 Underlying: Common Stock, $0.10 par value · 835 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionMarket Share Units · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · derivative · entry 13 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 546 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 1,359 | $63.11 | $85,766.49 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 12 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,711 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 11 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,070 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 5,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 10 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 374 | $63.11 | $23,603.14 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 9 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,905 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 8 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,279 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 7 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 296 | $63.11 | $18,680.56 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 6 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,408 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 146 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 5 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,704 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 4 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Tax withholdingCommon Stock, $0.10 par value | 219 | $63.11 | $13,821.09 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 3 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
OtherCommon Stock, $0.10 par value | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 2 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,234 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:31 UTC |
Hoch LynellePresident, Cell Therapy Org.
|
Exercise / conversionCommon Stock, $0.10 par value | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000065 · wk-form4_1741829503.xml · nonDerivative · entry 1 Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 23,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 19 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,598 Underlying: Common Stock, $0.10 par value · 23,598 shares Expires 2028-03-10 F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionPerformance Shares · Derivative | 4,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 18 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,861 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
GrantMarket Share Units · Derivative | 15,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 17 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,732 Underlying: Common Stock, $0.10 par value · 15,732 shares Expires 2028-03-10 F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F12 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionMarket Share Units · Derivative | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 16 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,608 Underlying: Common Stock, $0.10 par value · 803 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionMarket Share Units · Derivative | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 15 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 811 Underlying: Common Stock, $0.10 par value · 810 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionMarket Share Units · Derivative | 690 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · derivative · entry 14 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 690 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 1,557 | $63.11 | $98,262.27 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 12 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,196 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 1,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 11 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,753 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 4,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 10 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 241 | $63.11 | $15,209.51 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 9 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,685 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 8 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,926 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 7 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 242 | $63.11 | $15,272.62 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 6 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,260 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 141 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 5 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,502 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 4 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Tax withholdingCommon Stock, $0.10 par value | 233 | $63.11 | $14,704.63 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 3 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,833 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
OtherCommon Stock, $0.10 par value | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 2 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,066 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC |
Poole Ahn AmandaEVP, Chief People Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 690 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000067 · wk-form4_1741829571.xml · nonDerivative · entry 1 Poole Ahn Amanda · CIK 0002005210 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
GrantPerformance Shares · Derivative | 47,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 20 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,197 Underlying: Common Stock, $0.10 par value · 47,197 shares Expires 2028-03-10 F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionPerformance Shares · Derivative | 10,955 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 19 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 10,955 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
GrantMarket Share Units · Derivative | 31,464 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 18 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,464 Underlying: Common Stock, $0.10 par value · 31,464 shares Expires 2028-03-10 F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F12 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionMarket Share Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 17 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,001 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionMarket Share Units · Derivative | 1,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 16 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,828 Underlying: Common Stock, $0.10 par value · 1,825 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionMarket Share Units · Derivative | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · derivative · entry 15 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 1,904 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 3,538 | $63.11 | $223,283.18 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 12 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,439 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
OtherCommon Stock, $0.10 par value | 4,040 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 11 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,977 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 10,955 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 10 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 849 | $63.11 | $53,580.39 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 9 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,062 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
OtherCommon Stock, $0.10 par value | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 8 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,911 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 7 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 771 | $63.11 | $48,657.81 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 6 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
OtherCommon Stock, $0.10 par value | 318 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 5 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,023 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:34 UTC |
Lenkowsky AdamEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 1,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000069 · wk-form4_1741829659.xml · nonDerivative · entry 4 Lenkowsky Adam · CIK 0001975719 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.